Quercetin Potentiates the Antitumor Activity of Rituximab in Diffuse Large B-Cell Lymphoma by Inhibiting STAT3 Pathway
Xin Li(China Medical University), Yu Qi(First Affiliated Hospital of Zhengzhou University), Mingzhi Zhang(Chinese Academy of Sciences), Aimin Li(Hebei Medical University), Xinhua Wang(First Affiliated Hospital of Zhengzhou University), Zhenchang Sun(First Affiliated Hospital of Zhengzhou University)
Cited by 17
Related Papers
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
|Journal of Hematology & Oncology|2016|250
Reversing insufficient photothermal therapy-induced tumor relapse and metastasis by regulating cancer-associated fibroblasts
|Nature Communications|2022|247
Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105–125
|The EMBO Journal|2007|213
miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42
|Digestive Diseases and Sciences|2011|140